Par Pharmaceutical, Inc. et al v. Amneal Pharmaceuticals Company GmbH et al
Par Pharmaceutical, Inc., Par Sterile Products, LLC and Endo Par Innovation Company, LLC |
Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceutical Holding Company LLC, Amneal Biosciences LLC, Amneal Pharmaceuticals Pvt. Ltd. and Amneal Pharmaceuticals Company GmbH |
1:2019cv00712 |
April 18, 2019 |
US District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on July 3, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 18 ANSWER to #13 Answer to Complaint,, Counterclaim, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Brian) |
Filing 17 ORDER, this case having been listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before July 29, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 7/29/2019.) Signed by Judge Colm F. Connolly on 6/28/2019. (nmf) |
Filing 16 SO ORDERED, re #12 Stipulation of Dismissal filed by Amneal Pharmaceutical Holding Company LLC. Party Amneal Pharmaceutical Holding Company LLC terminated. Signed by Judge Colm F. Connolly on 6/13/2019. (fms) |
Filing 15 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals Holding GmbH for Amneal Pharmaceuticals Company GmbH; Corporate Parent Amneal Pharmaceuticals LLC for Amneal Biosciences LLC, Amneal Pharmaceuticals of New York, LLC; Corporate Parent Amneal Singapore Pvt. Ltd. for Amneal Pharmaceuticals Pvt. Ltd. filed by Amneal Biosciences LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC. (Gaza, Anne) |
Filing 14 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,375.478 B1 ;US 9,687,526 B2 ;US 9,744,239 B2 . (Gaza, Anne) |
Filing 13 ANSWER to #1 Complaint, Defenses and, COUNTERCLAIM against Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC by Amneal Pharmaceuticals of New York, LLC, Amneal Biosciences LLC, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals Company GmbH. (Attachments: #1 Exhibit 1 - 3)(Gaza, Anne) |
Filing 12 STIPULATION of Dismissal as to Defendant Amneal Pharmaceuticals Holding Company, LLC by Amneal Pharmaceutical Holding Company LLC. (Gaza, Anne) |
Pro Hac Vice Attorney Blake B. Greene for Endo Par Innovation Company, LLC, for Par Pharmaceutical, Inc., for Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Blake B. Greene filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 6/4/2019. (fms) |
Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Blake B. Greene - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian) |
Filing 10 STIPULATION TO EXTEND TIME for Defendants Amneal Pharmaceutical Company GmbH, Amneal Pharmaceuticals of New York, LLC, Amneal Biosciences LLC, and Amneal Pharmaceuticals Pvt. Ltd. to move against, answer, or otherwise plead in response to the Complaint to June 12, 2019 - filed by Amneal Biosciences LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC. (Gaza, Anne) |
SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendant Amneal Pharmaceutical Holding Company LLC to move against, answer, or otherwise plead in response to the Complaint to June 12, 2019 filed by Amneal Pharmaceutical Holding Company LLC, Set/Reset Answer Deadlines: Amneal Pharmaceutical Holding Company LLC answer due 6/12/2019. Signed by Judge Colm F. Connolly on 5/13/2019. (fms) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME for Defendants Amneal Pharmaceutical Company GmbH, Amneal Pharmaceuticals of New York, LLC, Amneal Biosciences LLC, and Amneal Pharmaceuticals Pvt. Ltd. to move against, answer, or otherwise plead in response to the Complaint. Set/Reset Answer Deadlines: Amneal Biosciences LLC answer due 6/12/2019; Amneal Pharmaceuticals Company GmbH answer due 6/12/2019; Amneal Pharmaceuticals Pvt. Ltd. answer due 6/12/2019; Amneal Pharmaceuticals of New York, LLC answer due 6/12/2019. Signed by Judge Colm F. Connolly on 5/13/2019. (fms) |
Filing 9 STIPULATION TO EXTEND TIME for Defendant Amneal Pharmaceutical Holding Company LLC to move against, answer, or otherwise plead in response to the Complaint to June 12, 2019 - filed by Amneal Pharmaceutical Holding Company LLC. (Gaza, Anne) |
Pro Hac Vice Attorney Sharon K. Gagliardi for Endo Par Innovation Company, LLC, for Par Pharmaceutical, Inc., for Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 5/7/2019. (fms) |
Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian) |
Pro Hac Vice Attorney Robert D. Rhoad for Endo Par Innovation Company, LLC, for Par Pharmaceutical, Inc., for Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
Filing 7 SUMMONS Returned Executed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Amneal Pharmaceuticals Company GmbH served on 4/30/2019, answer due 5/21/2019. (Farnan, Brian) |
Pro Hac Vice Attorney Brian M. Goldberg for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., and Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
Summons Reissued with Magistrate Consent Notice attached as to Amneal Pharmaceuticals of New York, LLC. (amf) |
Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Brian M. Goldberg and Robert D. Rhoad - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian) |
SO ORDERED, re #6 MOTION for Pro Hac Vice Appearance of Attorney Brian M. Goldberg and Robert D. Rhoad filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 4/29/2019. (fms) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
Filing 5 SUMMONS Returned Executed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. Amneal Biosciences LLC served on 4/22/2019, answer due 5/13/2019; Amneal Pharmaceutical Holding Company LLC served on 4/22/2019, answer due 5/13/2019; Amneal Pharmaceuticals Company GmbH served on 4/22/2019, answer due 5/13/2019; Amneal Pharmaceuticals of New York, LLC served on 4/22/2019, answer due 5/13/2019. (Farnan, Brian) |
Summons Issued with Magistrate Consent Notice attached as to Amneal Biosciences LLC on 4/22/2019; Amneal Pharmaceutical Holding Company LLC on 4/22/2019; Amneal Pharmaceuticals Company GmbH on 4/22/2019; Amneal Pharmaceuticals of New York, LLC on 4/22/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ddp) |
CORRECTING ENTRY: Corrected docket clerk error and replaced D.I. 4 with correct document (ddp) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,744,209 B2 ;US 9,750,785 B2. (ddp) (Main Document 4 replaced on 4/22/2019) (ddp). |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/6/2019. Date of Expiration of Patent: 1/30/2035.Thirty Month Stay Deadline: 9/6/2021. (ddp) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ddp) |
Filing 1 COMPLAINT filed against Amneal Biosciences LLC, Amneal Pharmaceutical Holding Company LLC, Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals Pvt. Ltd., Amneal Pharmaceuticals of New York, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2622968.) - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(ddp) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.